Skip to main content
. 2020 Sep 30;55(3):131–138. doi: 10.5045/br.2020.2020080

Fig. 1.

Fig. 1

Peak patterns from a CLL case with trisomy 12 (dosage quotient, -1.5) and heterozygous 13q14 deletion (dosage quotient, -0.7).